BMI Requirements: Semaglutide is generally not recommended for individuals with a BMI below 27 unless they have an obesity-related medical condition
The odds ratio for vomiting with cagrilintide versus semaglutide or liraglutide was 0.38, meaning cagrilintide caused vomiting at roughly one-third the rate
In addition to their effects on NO, GLP-1RAs also exert antioxidant effects
The SI 75 value obtained was approximately 2.4, indicating that CPP-CAND also exhibited selectivity for senescent cancer cells induced by other anticancer drugs (Figure
Beyond VAT reduction, participants often reported improvements in how they perceived their abdominal shapea reminder that metabolic therapies can also influence quality of life in ways not captured by laboratory values alone (Brown & Glesby, 2023)
She takes the time to explain the science behind IV nutrient therapy, discuss the specific benefits of each formulation, and set realistic expectations for outcomes